Metabolic Syndrome in Psychotic Disorder Patients Treated With Oral and Long-Acting Injected Antipsychotics

Background: Severe mental illnesses are associated with increased risks for metabolic syndrome (MetS) and other medical disorders, often with unfavorable outcomes. MetS may be more likely with schizoaffective disorder (SzAff) than schizophrenia (Sz). MetS is associated with long-term antipsychotic d...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Antonio Ventriglio, Ross J. Baldessarini, Giovanna Vitrani, Iris Bonfitto, Angela Chiara Cecere, Angelo Rinaldi, Annamaria Petito, Antonello Bellomo
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2019-01-01
Saila:	Frontiers in Psychiatry
Gaiak:	metabolic syndrome antipsychotics long-acting injected schizoaffective schizophrenia
Sarrera elektronikoa:	https://www.frontiersin.org/article/10.3389/fpsyt.2018.00744/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!